Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 137

1.

Mavoglurant in Parkinson's patients with l-Dopa-induced dyskinesias: Two randomized phase 2 studies.

Trenkwalder C, Stocchi F, Poewe W, Dronamraju N, Kenney C, Shah A, von Raison F, Graf A.

Mov Disord. 2016 Jul;31(7):1054-8. doi: 10.1002/mds.26585. Epub 2016 May 23.

PMID:
27214258
2.

'It pushed me back into the human race': evaluative findings from a community Christmas event.

Collins T, Kenney C, Hesk G.

Health Soc Care Community. 2016 Mar 9. doi: 10.1111/hsc.12342. [Epub ahead of print]

PMID:
26956945
3.

Erratum: "Examination of the Safety of Pediatric Vaccine Schedules in a Non-Human Primate Model: Assessments of Neurodevelopment, Learning, and Social Behavior".

Curtis B, Liberato N, Rulien M, Morrisroe K, Kenney C, Yutuc V, Ferrier C, Marti CN, Mandell D, Burbacher TM, Sackett GP, Hewitson L.

Environ Health Perspect. 2016 Jan;124(1):A11. doi: 10.1289/ehp.124-A11. No abstract available.

4.

Relationship between prenatal cortisol exposure and behavioral development in macaque monkeys.

Meyer J, Grant K, Burbacher T, Worlein J, Kenney C, Dettmer A, Suomi S, Hamel A, Rosenberg K, Novak M.

Psychoneuroendocrinology. 2015 Nov;61:30-1. doi: 10.1016/j.psyneuen.2015.07.473. Epub 2015 Aug 8. No abstract available.

PMID:
26383357
5.

How undergraduate students can contribute to EBP.

Schreiner M, Kudrna B, Kenney C.

Nurs Manage. 2015 Sep;46(9):21-3. doi: 10.1097/01.NUMA.0000470777.48225.b5. No abstract available.

PMID:
26295599
6.

X-ray detectors at the Linac Coherent Light Source.

Blaj G, Caragiulo P, Carini G, Carron S, Dragone A, Freytag D, Haller G, Hart P, Hasi J, Herbst R, Herrmann S, Kenney C, Markovic B, Nishimura K, Osier S, Pines J, Reese B, Segal J, Tomada A, Weaver M.

J Synchrotron Radiat. 2015 May;22(3):577-83. doi: 10.1107/S1600577515005317. Epub 2015 Apr 21.

7.

Atrial premature beats predict atrial fibrillation in cryptogenic stroke: results from the EMBRACE trial.

Gladstone DJ, Dorian P, Spring M, Panzov V, Mamdani M, Healey JS, Thorpe KE; EMBRACE Steering Committee and Investigators.

Stroke. 2015 Apr;46(4):936-41. doi: 10.1161/STROKEAHA.115.008714. Epub 2015 Feb 19.

8.

Examination of the safety of pediatric vaccine schedules in a non-human primate model: assessments of neurodevelopment, learning, and social behavior.

Curtis B, Liberato N, Rulien M, Morrisroe K, Kenney C, Yutuc V, Ferrier C, Marti CN, Mandell D, Burbacher TM, Sackett GP, Hewitson L.

Environ Health Perspect. 2015 Jun;123(6):579-89. doi: 10.1289/ehp.1408257. Epub 2015 Feb 18. Erratum in: Environ Health Perspect. 2016 Jan;124(1):A11.

9.

Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion.

Coutts SB, Dubuc V, Mandzia J, Kenney C, Demchuk AM, Smith EE, Subramaniam S, Goyal M, Patil S, Menon BK, Barber PA, Dowlatshahi D, Field T, Asdaghi N, Camden MC, Hill MD; TEMPO-1 Investigators.

Stroke. 2015 Mar;46(3):769-74. doi: 10.1161/STROKEAHA.114.008504. Epub 2015 Feb 12.

10.

Randomized assessment of rapid endovascular treatment of ischemic stroke.

Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, Roy D, Jovin TG, Willinsky RA, Sapkota BL, Dowlatshahi D, Frei DF, Kamal NR, Montanera WJ, Poppe AY, Ryckborst KJ, Silver FL, Shuaib A, Tampieri D, Williams D, Bang OY, Baxter BW, Burns PA, Choe H, Heo JH, Holmstedt CA, Jankowitz B, Kelly M, Linares G, Mandzia JL, Shankar J, Sohn SI, Swartz RH, Barber PA, Coutts SB, Smith EE, Morrish WF, Weill A, Subramaniam S, Mitha AP, Wong JH, Lowerison MW, Sajobi TT, Hill MD; ESCAPE Trial Investigators.

N Engl J Med. 2015 Mar 12;372(11):1019-30. doi: 10.1056/NEJMoa1414905. Epub 2015 Feb 11.

11.

Assessment of Parkinson's disease levodopa-induced dyskinesia: a qualitative research study.

Lenderking WR, Mannix S, Petrillo J, Kenney C, Landrian A, Schrag AE.

Qual Life Res. 2015 Aug;24(8):1899-910. doi: 10.1007/s11136-015-0925-7. Epub 2015 Feb 6.

PMID:
25655015
12.
13.

Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial.

Hauser RA, Olanow CW, Kieburtz KD, Pourcher E, Docu-Axelerad A, Lew M, Kozyolkin O, Neale A, Resburg C, Meya U, Kenney C, Bandak S.

Lancet Neurol. 2014 Aug;13(8):767-76. doi: 10.1016/S1474-4422(14)70148-6. Epub 2014 Jul 6.

PMID:
25008546
14.

Atrial fibrillation in patients with cryptogenic stroke.

Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J, Vaid H, O'Donnell M, Laupacis A, Côté R, Sharma M, Blakely JA, Shuaib A, Hachinski V, Coutts SB, Sahlas DJ, Teal P, Yip S, Spence JD, Buck B, Verreault S, Casaubon LK, Penn A, Selchen D, Jin A, Howse D, Mehdiratta M, Boyle K, Aviv R, Kapral MK, Mamdani M; EMBRACE Investigators and Coordinators.

N Engl J Med. 2014 Jun 26;370(26):2467-77. doi: 10.1056/NEJMoa1311376.

15.

Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias.

Rascol O, Fox S, Gasparini F, Kenney C, Di Paolo T, Gomez-Mancilla B.

Parkinsonism Relat Disord. 2014 Sep;20(9):947-56. doi: 10.1016/j.parkreldis.2014.05.003. Epub 2014 May 14. Review.

PMID:
24951359
16.

Management of non-parasitic splenic cysts: does size really matter?

Kenney CD, Hoeger YE, Yetasook AK, Linn JG, Denham EW, Carbray J, Ujiki MB.

J Gastrointest Surg. 2014 Sep;18(9):1658-63. doi: 10.1007/s11605-014-2545-x. Epub 2014 May 29.

PMID:
24871081
17.

Radiographic findings in Waldenström's macroglobulinemia resembling fibrogenesis imperfecta ossium (FIO): a case report.

Epperla N, McKiernan FE, Kenney CV.

Skeletal Radiol. 2014 Mar;43(3):381-5. doi: 10.1007/s00256-013-1734-0. Epub 2013 Sep 27.

PMID:
24072255
18.

Mavoglurant (AFQ056) in combination with increased levodopa dosages in Parkinson's disease patients.

Kumar R, Hauser RA, Mostillo J, Dronamraju N, Graf A, Merschhemke M, Kenney C.

Int J Neurosci. 2016;126(1):20-4. doi: 10.3109/00207454.2013.841685. Epub 2015 Aug 18.

PMID:
24007304
19.

AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.

Stocchi F, Rascol O, Destee A, Hattori N, Hauser RA, Lang AE, Poewe W, Stacy M, Tolosa E, Gao H, Nagel J, Merschhemke M, Graf A, Kenney C, Trenkwalder C.

Mov Disord. 2013 Nov;28(13):1838-46. doi: 10.1002/mds.25561. Epub 2013 Jul 12.

PMID:
23853029
20.

Closure of patent foramen ovale versus medical therapy after cryptogenic stroke.

Carroll JD, Saver JL, Thaler DE, Smalling RW, Berry S, MacDonald LA, Marks DS, Tirschwell DL; RESPECT Investigators.

N Engl J Med. 2013 Mar 21;368(12):1092-100. doi: 10.1056/NEJMoa1301440.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk